| Bextra has been the frequent topic of new stories lately, although most of the publicity has been decidedly negative. Reports of elevated risks of stroke, heart attack, and fatal skin allergies have dominated recent events, culminating with the Food and Drug Administration press release asking for the removal of Bextra from American and European markets.
After this release by the FDA, many new services from across the country and around the world added their insight to an already complicated case, providing new material for those individuals who took Bextra to form a reasoned and informed view on the risks of the drug.
DRUG ADS SHOW 'BEXTRA' CAUTION
The withdrawal of two once-heralded painkillers within
months is putting pressure on Big Pharma to take a hard
look at its marketing tactics.
Aetna Informs Members and Physicians about Bextra
Aetna (NYSE:AET) announced today it is contacting more
than 33,000 members who have used Bextra(R) to inform
them directly about the U.S. Food and Drug Administration's
(FDA) decision to ask that Bextra be withdrawn from the
market.
Chicago Firm Files Class Action Suit Against Pfizer
Over Bextra
The first of the lawsuits has been filed now against Pfizer
- the maker of the painkiller Bextra - which was taken
off the market last Thursday after reports linked it to
heart attacks, strokes, and a skin condition.
Bextra Lawsuits Filed Against Pfizer in New York
Three Bextra lawsuits were filed against Pfizer Inc.
on behalf of three individuals who allegedly were injured
by the pain relief drug, Bextra, the Philadelphia law
firm Kline & Specter, P.C. announced Monday in a
statement.
Painkiller Bextra pulled from shelves
Pfizer Inc. pulled its troubled painkiller Bextra from
U.S. and European pharmacies Thursday after the Food
and Drug Administration said the medication posed a risk
of rare but life-threatening skin reactions.
Pfizer's Bextra Goes Bust
Pfizer arthritis drug Bextra has been pulled from the
market by the Food and Drug Administration (FDA) amid
concerns the risks outweigh the benefits.
Painkiller Bextra taken off market
The painkiller Bextra was taken off the market Thursday,
and the government wants similar prescription drugs to
carry the strongest possible warnings about increased risk
of heart attack and stroke among the millions of people
who rely on them.
Pfizer Takes Painkiller Bextra Off Market
Pfizer says it has suspended sales of Bextra in the United
States and the European Union at the request of the Food
and Drug Administration and European regulators.
Pfizer Suspends Bextra, Agrees to Warning on Celebrex
Pfizer Inc., the world's biggest drugmaker, suspended
sales of the Bextra painkiller at the request of U.S.
regulators and agreed to apply the government's strictest
warnings to its similar Celebrex drug.
Pfizer Takes Painkiller Bextra Off Market
The painkiller Bextra was taken off the market Thursday,
and the government wants other drugs in the same class
to carry the strongest possible warnings about increased
risk of heart attack and stroke among the millions of
people who rely on them.
Pfizer Halts Bextra Sales in U.S., Europe
Pfizer Inc. on Thursday agreed to suspend sales of its
arthritis drug Bextra after U.S. and European regulators
said the risk of serious side effects, including a potentially
fatal skin allergy, outweigh the benefits.
Ban on Pfizer's Bextra Extends Beyond U.S.
Hong Kong suspended the sale of the painkiller Bextra
on Friday -- one day after the drug was pulled off U.S.
shelves because it has been linked to increased risk
of heart attacks and a rare skin condition.
Painkiller Decision Suggests Shift In FDA's Risk-Benefit
Equation
The Food and Drug Administration's dramatic decision Thursday
to rein in the use of a wide array of popular painkillers
reflects a broader shift at the powerful agency, which
has been battered by six months of controversy over its
handling of drug safety issues, say observers in academia
and industry and public health advocates.
Bextra Pulled Off Market; FDA Cites Patient Health Risks
The Federal Drug Administration is concerned about the
side effects of Bextra.
Bextra Removed from Market
At issue is a class of painkillers known as nonsteroidal
antiflammatory drugs, which include prescription medications
Vioxx and Celebrex, as well as over-the-counter drugs
such as Motrin and Advil, which are ibuprofens, and Aleve
and Naprosyn, which are naproxens.
|
